Absence of the transcription factor E2F1 attenuates brain injury and improves behavior after focal ischemia in mice

John P MacManus1, Ming Jian, Edward Preston

  • 1Institute for Biological Sciences, National Research Council of Canada, Ottawa, Canada. John.MacManus@NRC.CA

Insights

Mice lacking the transcription factor E2F1 showed significantly reduced brain damage and improved motor function following ischemic stroke. This suggests E2F1 plays a role in neuronal cell death after cerebral ischemia.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • Cultured neurons lacking the transcription factor E2F1 (E2F1-null) display resistance to cell death inducers.
  • This resistance suggests a potential role for E2F1 in neuronal vulnerability to injury.

Purpose of the Study:

  • To investigate if E2F1 deficiency confers resistance to cerebral ischemic injury in vivo.
  • To determine the impact of E2F1 on neuronal damage and functional recovery after stroke.

Main Methods:

  • Cerebral ischemia was induced in E2F1-null mice and littermate controls using middle cerebral artery occlusion.
  • Infarct volume was quantified using 2,3,5-triphenyltetrazolium staining.
  • Neuronal damage was assessed via immunohistochemistry for microtubule-associated protein 2 and DNA fragmentation (TUNEL assay).
  • Behavioral tests evaluated motor function recovery.
  • Quantitative polymerase chain reaction measured the expression of E2F1 target genes.

Main Results:

  • E2F1-null mice exhibited significantly smaller infarct volumes (33-71% reduction) after varying durations of ischemia compared to controls.
  • Reduced neuronal damage and DNA fragmentation were observed in E2F1-null mice.
  • E2F1-null mice demonstrated improved motor function recovery post-stroke.
  • No significant changes in key pro-apoptotic gene expression were detected, hindering mechanistic inference.

Conclusions:

  • The transcription factor E2F1 modulates neuronal viability in the brain following cerebral ischemia.
  • E2F1 deficiency confers neuroprotection against ischemic stroke, corroborating in vitro findings.

Related Concept Videos